ArticleMetabolites2021

The Impact of Simvastatin on Lipidomic Markers of Cardiovascular Risk in Human Liver Cells Is Secondary to the Modulation of Intracellular Cholesterol.

Yvette L Schooneveldt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.